deltatrials
Completed OBSERVATIONAL NCT04068168

Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS) (Imfinzi PMS)

Sponsor: AstraZeneca

Conditions Lung Cancer, Biliary Tract Cancer
Updated 45 times since 2019 Last updated: Nov 14, 2025 Started: Jan 30, 2020 Primary completion: Dec 27, 2024 Completion: Dec 27, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Lung Cancer, Biliary Tract Cancer and is currently completed. AstraZeneca leads this study, which shows 45 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Mar 2020 · 4 months · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Sep 2022 · 4 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Aug 2023 · 2 months · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Nov 2023 · 2 months · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Feb 2024 · 2 months · monthly snapshot~Feb 2024 – ~Apr 2024 · 2 months · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Dec 2024 · 2 months · monthly snapshot~Dec 2024 – ~Jan 2025 · 31 days · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – ~Dec 2025 · 3 months · monthly snapshot~Dec 2025 – present · 7 months · monthly snapshot

Change History

45 versions recorded

  1. Dec 2025 — Present [monthly]

    Completed

  2. Sep 2025 — Dec 2025 [monthly]

    Completed

  3. Feb 2025 — Sep 2025 [monthly]

    Completed

    Status: Recruiting → Completed

  4. Jan 2025 — Feb 2025 [monthly]

    Recruiting

  5. Dec 2024 — Jan 2025 [monthly]

    Recruiting

▶ Show 40 earlier versions

  1. Oct 2024 — Dec 2024 [monthly]

    Recruiting

  2. Sep 2024 — Oct 2024 [monthly]

    Recruiting

  3. Aug 2024 — Sep 2024 [monthly]

    Recruiting

  4. Jul 2024 — Aug 2024 [monthly]

    Recruiting

  5. May 2024 — Jul 2024 [monthly]

    Recruiting

  6. Apr 2024 — May 2024 [monthly]

    Recruiting

  7. Feb 2024 — Apr 2024 [monthly]

    Recruiting

  8. Dec 2023 — Feb 2024 [monthly]

    Recruiting

  9. Nov 2023 — Dec 2023 [monthly]

    Recruiting

  10. Sep 2023 — Nov 2023 [monthly]

    Recruiting

  11. Aug 2023 — Sep 2023 [monthly]

    Recruiting

  12. Jun 2023 — Aug 2023 [monthly]

    Recruiting

  13. May 2023 — Jun 2023 [monthly]

    Recruiting

  14. Apr 2023 — May 2023 [monthly]

    Recruiting

  15. Mar 2023 — Apr 2023 [monthly]

    Recruiting

  16. Feb 2023 — Mar 2023 [monthly]

    Recruiting

  17. Dec 2022 — Feb 2023 [monthly]

    Recruiting

  18. Sep 2022 — Dec 2022 [monthly]

    Recruiting

  19. May 2022 — Sep 2022 [monthly]

    Recruiting

  20. Apr 2022 — May 2022 [monthly]

    Recruiting

  21. Mar 2022 — Apr 2022 [monthly]

    Recruiting

  22. Jan 2022 — Mar 2022 [monthly]

    Recruiting

  23. Dec 2021 — Jan 2022 [monthly]

    Recruiting

  24. Oct 2021 — Dec 2021 [monthly]

    Recruiting

  25. Sep 2021 — Oct 2021 [monthly]

    Recruiting

  26. Jun 2021 — Sep 2021 [monthly]

    Recruiting

  27. May 2021 — Jun 2021 [monthly]

    Recruiting

  28. Apr 2021 — May 2021 [monthly]

    Recruiting

  29. Feb 2021 — Apr 2021 [monthly]

    Recruiting

  30. Jan 2021 — Feb 2021 [monthly]

    Recruiting

  31. Dec 2020 — Jan 2021 [monthly]

    Recruiting

  32. Nov 2020 — Dec 2020 [monthly]

    Recruiting

  33. Sep 2020 — Nov 2020 [monthly]

    Recruiting

  34. Aug 2020 — Sep 2020 [monthly]

    Recruiting

  35. Jul 2020 — Aug 2020 [monthly]

    Recruiting

  36. May 2020 — Jul 2020 [monthly]

    Recruiting

  37. Apr 2020 — May 2020 [monthly]

    Recruiting

  38. Mar 2020 — Apr 2020 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  39. Nov 2019 — Mar 2020 [monthly]

    Not Yet Recruiting

  40. Sep 2019 — Nov 2019 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anyang-si, South Korea , Bucheon-si, South Korea , Busan, South Korea , Changwon, South Korea , Changwon-si, South Korea , Cheonan, South Korea , Chuncheon, South Korea , Daegu, South Korea , Daejeon, South Korea , Goyang-si, South Korea and 14 more locations